1Siragy H.angiotensin II receptor blockers: review of the binding characteristics.Am J Cardiol,1999,84(10A):3～8.
2Prasad A,Tupas-Habib T,Schenke WH,et al.acute and chronic angiotehsin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis.Circulation,2000,101(20):2349～2354.
3Schiffrin EL,Park JB,Intengan ⅡD, et al.correction of artenal structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.Circulation,2000,101(14): 1653～1659.
4Strawn WB,Chappell MC,Dean RH, et al.inhibition of early ath erosclerosis by losartan in monkeys with diet-induced hypercholestero-lemia.Circulation,2000,101(13):1586～1593.
5Thurmann P.angiotensin II antagonism and the heart:valsartan in left ventricular hypertrophy.J Cardiovasc Pharmacol,1999,33(Suppl 1):s 33～36.
6Avanza AC Jr,EI Aouar LM.Mill JC reduction in left ventri-cular hypertrophy in hypertensive patients treated with enalapril,losar-tan or combination of enalapril and losartan.Arq Beas Cardiol, 2000,74(2):103～117.
7Laviades C,Varo N,Diez J.transforming growth factor beta in hypertensivers with cardiorenal damage.Hypertension,2000, 36(4):517～522.
8Mazzolai L,Pedrazzini T,Nicoud F,et al.increased cardiac an-giotensin II levels induce right and left ventricular hypertrophy in nor-motensive mice Hypertension,2000,35:985.
9Pinto YM,Pinto-Sietsma SJ,Philipp T,et al.reduction in left ventricular messenger RNA for transforming growth facter bet(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive tgr(mren2)27rat.hypertension,2000,36(5):747～754.
